Target intelligence / Profile preview

Human Immunodeficiency Virus Type 1 Capsid Protein p24 (Gag p24)

Target: Gag p24
Molecular classification: Viral structural protein, Gag protein

Overview

The HIV-1 Gag p24 protein is a major structural component of the viral capsid. It is essential for maintaining capsid integrity and protecting the viral RNA genome. p24 is also involved in the assembly and release of new virions. It serves as an early marker of HIV-1 infection and is used to monitor viral load during antiretroviral therapy.

Other names: HIV-1 p24p24 capsid proteinCA

Biological functions

Capsid formationViral RNA protectionViral assemblyViral release

Disease associations

HIV-1 infectionAIDS pathogenesis

Biomarkers

Early HIV-1 infectionViral load monitoringTreatment efficacy monitoringHIV reservoir activity

Beyond the preview

Go deeper on Human Immunodeficiency Virus Type 1 Capsid Protein p24 (Gag p24).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Human Immunodeficiency Virus Type 1 Capsid Protein p24 (Gag p24).

Explore the full profile